Cutler Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$7K Sell
5,500
-500
-8% -$718 ﹤0.01% 1446
2023
Q4
$8K Hold
6,000
﹤0.01% 2532
2023
Q3
$8K Hold
6,000
﹤0.01% 2612
2023
Q2
$6K Hold
6,000
﹤0.01% 2554
2023
Q1
$6K Sell
6,000
-1,026
-15% -$1.48K ﹤0.01% 2651
2022
Q4
$10K Hold
7,026
﹤0.01% 2707
2022
Q3
$14K Sell
7,026
-100
-1% -$211 ﹤0.01% 2882
2022
Q2
$9K Hold
7,126
﹤0.01% 3294
2022
Q1
$15K Sell
7,126
-2,500
-26% -$6.09K ﹤0.01% 3294
2021
Q4
$35K Buy
9,626
+1,326
+16% +$5.71K ﹤0.01% 2680
2021
Q3
$41K Buy
8,300
+2,300
+38% +$13.2K ﹤0.01% 2674
2021
Q2
$39K Hold
6,000
﹤0.01% 2709
2021
Q1
$41K Hold
6,000
﹤0.01% 2562
2020
Q4
$61K Sell
6,000
-5,300
-47% -$34.4K ﹤0.01% 1853
2020
Q3
$39K Hold
11,300
﹤0.01% 1963
2020
Q2
$56K Hold
11,300
﹤0.01% 1675
2020
Q1
$38K Sell
11,300
-11,700
-51% -$50.5K ﹤0.01% 1901
2019
Q4
$126K Hold
23,000
0.01% 1080
2019
Q3
$131K Hold
23,000
0.01% 923
2019
Q2
$176K Buy
23,000
+2,300
+11% +$12.4K 0.02% 786
2019
Q1
$108K Sell
20,700
-338
-2% -$2.34K 0.01% 973
2018
Q4
$137K Sell
21,038
-357
-2% -$4K 0.01% 848
2018
Q3
$368K Sell
21,395
-2,193
-9% -$32.6K 0.03% 582
2018
Q2
$328K Sell
23,588
-2,510
-10% -$42.4K 0.03% 581
2018
Q1
$400K Sell
26,098
-406
-2% -$5.8K 0.03% 495
2017
Q4
$305K Buy
26,504
+17,531
+195% +$261K 0.01% 752
2017
Q3
$170K Sell
8,973
-437
-5% -$8.99K 0.01% 1280
2017
Q2
$226K Buy
9,410
+5,310
+130% +$116K 0.01% 1183
2017
Q1
$81K Sell
4,100
-2,489
-38% -$55.6K ﹤0.01% 1938
2016
Q4
$158K Sell
6,589
-56,587
-90% -$1.58M 0.01% 1502
2016
Q3
$1.75M Buy
63,176
+45,985
+267% +$1.22M 0.08% 182
2016
Q2
$419K Sell
17,191
-263
-2% -$7.46K 0.02% 679
2016
Q1
$586K Sell
17,454
-7,719
-31% -$243K 0.04% 453
2015
Q4
$752K Buy
+25,173
New +$848K 0.04% 435

Other funds holding PGEN

Cutler Group's PGEN Position: Q1 2024 in Review

Cutler Group reduced its Precigen (PGEN) stake by 8.3% in Q1 2024, selling an estimated $718 and leaving 5,500 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Cutler Group first reported a position in PGEN in Q4 2015 and has held it in 34 quarters since. The position peaked at $1.75M in Q3 2016. 130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

  • Cutler Group held 5,500 shares of Precigen worth $7K as of Q1 2024.
  • Cutler Group sold 500 Precigen shares in Q1 2024, an estimated $718.
  • Precigen made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1446 holding.
  • Cutler Group first reported a position in Precigen in Q4 2015 and has held it in 34 quarters since.
  • Cutler Group's Precigen position peaked at $1.75M in Q3 2016.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.